Correlation Between Myriad Genetics and Guardant Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Myriad Genetics and Guardant Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Myriad Genetics and Guardant Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Myriad Genetics and Guardant Health, you can compare the effects of market volatilities on Myriad Genetics and Guardant Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Myriad Genetics with a short position of Guardant Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Myriad Genetics and Guardant Health.

Diversification Opportunities for Myriad Genetics and Guardant Health

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Myriad and Guardant is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Myriad Genetics and Guardant Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guardant Health and Myriad Genetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Myriad Genetics are associated (or correlated) with Guardant Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guardant Health has no effect on the direction of Myriad Genetics i.e., Myriad Genetics and Guardant Health go up and down completely randomly.

Pair Corralation between Myriad Genetics and Guardant Health

Given the investment horizon of 90 days Myriad Genetics is expected to under-perform the Guardant Health. But the stock apears to be less risky and, when comparing its historical volatility, Myriad Genetics is 1.27 times less risky than Guardant Health. The stock trades about -0.01 of its potential returns per unit of risk. The Guardant Health is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  2,517  in Guardant Health on August 26, 2024 and sell it today you would earn a total of  748.00  from holding Guardant Health or generate 29.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Myriad Genetics  vs.  Guardant Health

 Performance 
       Timeline  
Myriad Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Guardant Health 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Guardant Health are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, Guardant Health demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Myriad Genetics and Guardant Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Myriad Genetics and Guardant Health

The main advantage of trading using opposite Myriad Genetics and Guardant Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Myriad Genetics position performs unexpectedly, Guardant Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardant Health will offset losses from the drop in Guardant Health's long position.
The idea behind Myriad Genetics and Guardant Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings